Class / Patent application number | Description | Number of patent applications / Date published |
544339000 | Heptacyclo ring system having the diazine ring as one of the cyclos (e.g., indanthrones, etc.) | 7 |
20110112295 | TRICYCLIC SPACER SYSTEMS FOR NONLINEAR OPTICAL DEVICES - A compound for spacing nonlinear optical chromophores of the Formula I | 05-12-2011 |
544340000 | Chalcogen attached indirectly to the heptacyclo ring system by nonionic bonding | 4 |
20090005561 | Heterocyclical Chromophore Architectures - NLO chromophores of the form of Formula (I) and the acceptable salts, solvates and hydrates thereof, wherein Z, X | 01-01-2009 |
20110178301 | HETEROCYCLICAL CHROMOPHORE ARCHITECTURES - NLO chromophores of the form of Formula I: | 07-21-2011 |
20130345425 | HETEROCYCLICAL CHROMOPHORE ARCHITECTURES - NLO chromophores of the form of Formula I: | 12-26-2013 |
20140121376 | TRICYCLIC SPACER SYSTEMS FOR NONLINEAR OPTICAL DEVICES - A compound for spacing nonlinear optical chromophores of the Formula I | 05-01-2014 |
544341000 | Halogen, nitrogen, or carbon attached directly to the heptacyclo ring system by nonionic bonding | 2 |
20090143581 | SYNTHESIS OF AVRAINVILLAMIDE, STREPHACIDIN B, AND ANALOGUES THEREOF - The syntheses of the natural products, avrainvillamide and stephacidin B, are provided. The α,β-unsaturated nitrone functionality of avrainvillamide and its 3-alkylidene-3H-indole 1-oxide core is shown to covalently and reversibly bond to heteroatom-based nucleophiles. This capability may allow these molecules to bind active site nucleophiles and may provide the basis for designing potent and selective enzyme inhibitors. Both avrainvillamide and its dimer stephacidin B have been reported to exhibit antiproliferative activity, and avrainvillamide has been reported to exhibit antimicrobial activity against multi-drug resistant bacteria. Avrainvillamide has been found to target cytoskeleton-linking membrane protein (CLIMP-63) thereby preventing cells from undergoing mitosis. The invention provides syntheses of these natural products as well as analogs of these natural products and their functional cores. The compounds of the invention may be used in the treatment of diseases such as cancer, autoimmune diseases, and bacterial infection. | 06-04-2009 |
20110275814 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE - A material for an organic electroluminescence device including an indenofluorenedione derivative shown by the following formula (I): | 11-10-2011 |